Stock Price, News, Quote and Profile of SENSEONICS HOLDINGS INC(NYSEARCA:SENS) stock

SENSEONICS HOLDINGS INC

NYSEARCA:SENS (12/20/2024, 8:04:00 PM)

After market: 0.46 +0 (+0.04%)

0.4598

+0.02 (+4.03%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorHealth Care

GICS IndustryHealth Care Equipment & Supplies

GICS SubIndustryHealth Care Equipment

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Chartmill High Growth Momentum

EPS Q2Q%0%

Sales Q2Q%-30.08%

CRS53.91

6 Month21%

Overview

Earnings (Last)11-07 2024-11-07/amc

Earnings (Next)N/A N/A

Ins Owners4.66%

Inst Owners10.99%

Market Cap273.73M

Shares595.33M

PEN/A

Fwd PEN/A

Dividend YieldN/A

Analysts50

Short Float %7.32%

Short Ratio5.53

IPO03-04 2015-03-04

Stock Screener Links

American Stock Exchange Stock Screener

Find more stocks on American Stock Exchange

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. The company is headquartered in Germantown, Maryland and currently employs 132 full-time employees. The company went IPO on 2015-03-04. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every five minutes to a mobile app on the user's smartphone. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device. Its CGM system continually and accurately measures a person's glucose levels for up to six months.

Company Info

SENSEONICS HOLDINGS INC

20451 Seneca Meadows Pkwy

Germantown MARYLAND 20876

P: 13015157260

CEO: Timothy T. Goodnow

Employees: 132

Website: https://www.senseonics.com/

SENS News

9 days ago - ChartmillStay updated with the stocks that are on the move in today's after-hours session.

Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.

9 days ago - ChartmillTop movers in Friday's pre-market session

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

a month ago - Senseonics Holdings, Inc.Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences

GERMANTOWN, Md., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the...

2 months ago - Senseonics Holdings, Inc.Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering

$16 million upfront with the potential for an additional $16 million upon the exercise in full of warrants...

2 months ago - Senseonics Holdings, Inc.Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System

Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with management...

2 months ago - Senseonics Holdings, Inc.Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor

Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes...

SENSEONICS HOLDINGS INC (SENS)